Tag: mRNA-1273 Phase 3 program

Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program

Additional funding to support expanded mRNA-1273 clinical development plan including 30,000 participant…

Vinod Yalburgi Vinod Yalburgi